Warrant issuance with specific exercise prices and expiration dates
Company: Core Scientific
The claim, verbatim
Core Scientific issued Tranche 1 Warrants exercisable at $6.81 per share expiring January 23, 2027, and Tranche 2 Warrants exercisable at $0.01 per share contingent on stock price reaching $8.72 for 20 consecutive trading days, expiring January 23, 2029
Source (primary)
Core Scientific SC 13D/A filed 2024-02-20 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗
Quote: “Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $6.81 per share. Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of New Common Stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days. The Tranche 1 Warrants expire on January 23, 2027, and the Tranche 2 Warrants expire on January 23, 2029.”
How we checked this
Checked on September 18, 2026. The cited source supports every part of this claim.
The filing's description of the Warrant Agreement gives the exercise prices, the $8.72 twenty-day trigger for Tranche 2, and the 2027 and 2029 expiration dates. It also states that holders received these warrants under the Plan.
Confirmed in the source:
- Core Scientific issued Tranche 1 and Tranche 2 Warrants under a Warrant Agreement tied to its reorganization plan
- Tranche 1 Warrants are exercisable at $6.81 per share
- Tranche 1 Warrants expire on January 23, 2027
- Tranche 2 Warrants are exercisable at $0.01 per share only after the stock's volume weighted average price equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days
- Tranche 2 Warrants expire on January 23, 2029
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000119312524040126/d746411dsc13da.htm) in full (26,286 characters, retrieved August 31, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific SC 13D/A filed 2024-02-20
Quote: “Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $6.81 per share. Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of New Common Stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days. The Tranche 1 Warrants expire on January 23, 2027, and the Tranche 2 Warrants expire on January 23, 2029.”